New pharmaceutical protection against RSV, a virus potentially dangerous for infants and the elderly, has provided a global sales boost for the companies that won regulatory approval.
News
German panel endorses GSK, Pfizer RSV vaccines for elderly
August 9, 2024New pharmaceutical protection against RSV, a virus potentially dangerous for infants and the elderly, has provided a global sales boost for the companies that won regulatory approval.